BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204. [PMID: 20799931 DOI: 10.1186/1743-422x-7-204] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Biswas A, Panigrahi R, Chandra PK, Banerjee A, Datta S, Pal M, Chakraborty S, Bhattacharya P, Chakrabarti S, Chakravarty R. Characterization of the occult hepatitis B virus variants circulating among the blood donors from eastern India. ScientificWorldJournal 2013;2013:212704. [PMID: 24302857 DOI: 10.1155/2013/212704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Nna E, Mbamalu C, Ekejindu I. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health 2014;108:223-8. [PMID: 24995918 DOI: 10.1179/2047773214Y.0000000144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
3 Moresco MN, Virgolino Hde A, de Morais MP, da Motta-Passos I, Gomes-Gouvêa MS, de Assis LM, Aguiar KR, Lombardi SC, Malheiro A, Cavalheiro Nde P, Levi JE, Torres KL. Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy. Vox Sang 2014;107:19-25. [PMID: 24697276 DOI: 10.1111/vox.12125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
4 Sabat J, Dwibedi B, Dash L, Kar SK. Occult HBV infection in multi transfused thalassemia patients. Indian J Pediatr 2015;82:240-4. [PMID: 24928107 DOI: 10.1007/s12098-014-1490-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sinha M, Sundar K, Premalata CS, Asati V, Murali A, Bajpai AK, Davuluri S, Acharya KK, Lakshmaiah KC, Babu K G, Jacob LA, Nandan D, Velayutham D, Datta S, Jayshree RS. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection. Sci Rep 2019;9:14516. [PMID: 31601912 DOI: 10.1038/s41598-019-51157-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Besharat S, Katoonizadeh A, Moradi A. Potential mutations associated with occult hepatitis B virus status. Hepat Mon. 2014;14:e15275. [PMID: 24829588 DOI: 10.5812/hepatmon.15275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health 2016;110:287-91. [PMID: 27788631 DOI: 10.1080/20477724.2016.1248171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
8 Samiee S, Kanavi MR, Javadi MA, Bagheri A, Balagholi S, Hashemi MS. Real Time Polymerase Chain Reaction for Hepatitis B Screening in Donor Corneas in the Central Eye Bank of Iran. J Ophthalmic Vis Res 2018;13:392-6. [PMID: 30479707 DOI: 10.4103/jovr.jovr_157_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Abbasi S, Makvandi M, Karimi G, Neisi N. The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol 2016;9:e37329. [PMID: 27679708 DOI: 10.5812/jjm.37329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Liu GC, Sui GY, Liu GY, Zheng Y, Deng Y, Gao YY, Wang L. A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donors. PLoS One. 2013;8:e79203. [PMID: 24236110 DOI: 10.1371/journal.pone.0079203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Shen T, Yan XM. Hepatitis B virus genetic mutations and evolution in liver diseases. World J Gastroenterol 2014; 20(18): 5435-5441 [PMID: 24833874 DOI: 10.3748/wjg.v20.i18.5435] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
12 Arora S, Doda V, Kirtania T. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples. Blood Transfus. 2014;Oct 23; Epub ahead of print. [PMID: 25369612 DOI: 10.2450/2014.0048-14] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Shen T, Yan XM, Zhang JP, Wang JL, Zuo RX, Li L, Wang LP. Evolution of Hepatitis B Virus in a Chronic HBV-Infected Patient over 2 Years. Hepat Res Treat. 2011;2011:939148. [PMID: 21785721 DOI: 10.1155/2011/939148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
14 Ismail AM, Devakumar S, Anantharam R, Fletcher GJ, Subramani T, John GT, Daniel D, Abraham P. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus 2012;10:230-2. [PMID: 22153686 DOI: 10.2450/2011.0046-11] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
15 Shastry S, Bhat SS. Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis 2011;3:e2011062. [PMID: 22220259 DOI: 10.4084/MJHID.2011.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Saha D, Pal A, Sarkar N, Das D, Blackard JT, Guha SK, Saha B, Chakravarty R. Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. PLoS One. 2017;12:e0179035. [PMID: 28591184 DOI: 10.1371/journal.pone.0179035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
17 Mondal RK, Khatun M, Banerjee P, Ghosh A, Sarkar S, Santra A, Das K, Chowdhury A, Banerjee S, Datta S. Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers. Sci Rep 2017;7:9653. [PMID: 28852072 DOI: 10.1038/s41598-017-09965-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Sinha M, Rao CR, Premalata CS, Shafiulla M, Lakshmaiah KC, Jacob LA, Babu GK, Viveka BK, Appaji L, Subramanyam JR. Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian J Med Paediatr Oncol 2016;37:146-51. [PMID: 27688607 DOI: 10.4103/0971-5851.190353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Said ZN, Sayed MHE, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A, Esmat GE. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol 2013; 5(2): 64-73 [PMID: 23646231 DOI: 10.4254/wjh.v5.i2.64] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
21 Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17(15): 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
22 Saha D, Pal A, Biswas A, Panigrahi R, Sarkar N, Sarkar J, Pal M, Guha SK, Saha B, Chakrabarti S. Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS One. 2013;8:e73613. [PMID: 24023688 DOI: 10.1371/journal.pone.0073613] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
23 Sarkar J, Saha D, Bandyopadhyay B, Saha B, Kedia D, Guha Mazumder DN, Chakravarty R, Guha SK. Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India. Indian J Med Res 2016;143:636-42. [PMID: 27488008 DOI: 10.4103/0971-5916.187113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana. Genes (Basel) 2018;9:E453. [PMID: 30205537 DOI: 10.3390/genes9090453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]